Author:
Gitler Miriam S.,Boulay Sheila F.,Sood Virendar K.,McPherson Dan W.,(Russ) Knap F.F.,Zeeberg Barry R.,Reba Richard C.
Subject
Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience
Reference30 articles.
1. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease;Araujo;J. Neurochem.,1988
2. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases;Aubert;J. Neurochem.,1992
3. Cohen, V.I., Jin, B., Sood, V.K., Boulay, S.F., Zeeberg, B.R. and Reba, R.C., Synthesis and m2-selective antimuscarinic activity of 11-[[4-[4-(dialkylamino)butyl]-1-phenyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones, J. Med. Chem., in preparation.
4. Novel potent and m2-selective antimuscarinic compounds which penetrate the blood brain barrier;Cohen;Eur. J. Med. Chem.,1995
5. Preparation and Properties of (R)-(−)-1-Azabicyclo[2.2.2]Oct-3-yl-(R)-(+)-α-Hydroxy-α-(4-[125l]Iodophenyl)-α-Phenyl Acetate and (R)-(−)-1-Azabicyclo[2.2.2]Oct-3-Yl-(S)-(−)-α-hydroxy-α-(4-[125l]iodophenyl)-α-phenyl acetate as potential radiopharmaceuticals
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献